home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

46th Annual Meeting

 
  January 27, 2010  
     
 
DIA, Washington DC
Jun 13 2010 8:30AM - Jun 17 2010 12:30PM


 
Highlights 
 
 
The DIA Annual Meeting is "the event to attend" each year by biotechnology, pharmaceutical and regulatory professionals. There is no other industry meeting of its kind that can rival the breadth and depth of experience that this meeting delivers. With over 20 content-area tracks and 300 sessions, the presentations are geared to all experience levels of attendees, from R&D and regulatory leaders to professionals in specific functional areas. The DIA Annual Meeting, above all others, offers valuable professional cross-functional learning and networking experiences.

LEARNING OBJECTIVES
At the conclusion of this meeting, participants should be able to:
  • Describe the current regulatory and public policy environment pertaining to pharmaceuticals with an emphasis on the Food and Drug Administration;
  • Discuss the international regulations and economic factors that impact the global biopharmaceutical industry;
  • Recognize the challenges facing the FDA and the pharmaceutical industry in areas such as research study design and statistical methodology;
  • Recognize state-of-the-art clinical and statistical systems and implementations;
  • Recognize the written and communication skills needed to promote your career and your companys objectives;
  • Enhance your working relationship with colleagues, both locally and internationally;
  • Describe legal, advertising, and marketing issues related to providing product information;
  • Discuss statistics, economics, and quality of life science;
  • Enhance your knowledge of risk assessment and management in the areas such as computer systems validation and drug safety and pharmacovigilance;
  • Discuss issues in safety reporting, data analysis, epidemiology, and regulations regarding adverse events.
WHO SHOULD ATTEND

This program is designed for the full continuum of disciplines in the pharmaceutical and related industries to improve your understanding and skills as related to issues and solutions for a variety of pharmaceutical development interest areas.

 
 
Organized by: DIA WOrldwide Headquarters
Invited Speakers: See website
 
Deadline for Abstracts: See website
 
Registration: Contact Information:

Worldwide Headquarters

800 Enterprise Road, Suite 200Horsham, PA 19044-3595, USAPhone: +1 215 442 6100Fax: +1 215 442 6199

E-Mail: dia@diahome.org

E-mail: dia@diahome.org
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.